Chemistry: analytical and immunological testing – Involving producing or treating antigen or hapten – Producing labeled antigens
Reexamination Certificate
2005-04-15
2010-06-15
Haq, Shafiqul (Department: 1641)
Chemistry: analytical and immunological testing
Involving producing or treating antigen or hapten
Producing labeled antigens
C436S545000, C436S056000, C436S172000, C436S103000, C436S124000, C435S021000, C530S402000
Reexamination Certificate
active
07736911
ABSTRACT:
Provided are compounds capable of covalently binding to a protein tyrosine phosphatase (PTP). The compounds comprise Formula A:Also provided are compositions comprising one of the above compounds covalently bound to a member of the PTP superfamily, methods of labeling a PTP using the compounds, methods of isolating a PTP from a mixture of proteins using the compounds, methods of evaluating whether a substance is an inhibitor of a PTP using the compounds, methods of evaluating the specificity of an inhibitor of a PTP using the compounds, methods of identifying a PTP involved in a disease in a mammal using the compounds, and methods of diagnosing a disease in a mammal using the compounds.
REFERENCES:
patent: 5326905 (1994-07-01), Dow et al.
patent: 5714361 (1998-02-01), Widlanski
patent: 5763577 (1998-06-01), Bolton et al.
patent: 5770620 (1998-06-01), Mjalli et al.
patent: 5843707 (1998-12-01), Larsen et al.
patent: 5919813 (1999-07-01), De Juan, Jr.
patent: 6136798 (2000-10-01), Cody et al.
patent: 6174874 (2001-01-01), Wang et al.
patent: 6245742 (2001-06-01), Battistini et al.
patent: 6284914 (2001-09-01), Fujisawa et al.
patent: 6348572 (2002-02-01), Desmarais et al.
patent: 6365592 (2002-04-01), Leblanc et al.
patent: 6448429 (2002-09-01), Leblanc et al.
patent: 6465444 (2002-10-01), Bayly et al.
patent: 6486141 (2002-11-01), Lau et al.
patent: 6486142 (2002-11-01), Leblanc et al.
patent: 6498151 (2002-12-01), Li et al.
patent: 6583126 (2003-06-01), Leblanc et al.
patent: 6586467 (2003-07-01), Burgess et al.
patent: 6624152 (2003-09-01), Adams et al.
patent: 2002/0002149 (2002-01-01), Bayly et al.
patent: 2002/0040003 (2002-04-01), Burgess et al.
patent: 2002/0052344 (2002-05-01), Leblanc et al.
patent: 2002/0052346 (2002-05-01), Lau et al.
patent: 2002/0052347 (2002-05-01), Leblanc et al.
patent: 2002/0058644 (2002-05-01), Leblanc et al.
patent: 2002/0091104 (2002-07-01), Li et al.
patent: 2003/0004162 (2003-01-01), Treadway
patent: 2003/0083267 (2003-05-01), Adams et al.
patent: 2003/0114703 (2003-06-01), Leblanc et al.
patent: 2004/0002479 (2004-01-01), Wang et al.
patent: 2004/0005632 (2004-01-01), Erlanson et al.
patent: 2004/0191926 (2004-09-01), Zhang et al.
patent: WO 94/08600 (1994-04-01), None
patent: WO 95/25118 (1995-09-01), None
patent: WO 97/40017 (1997-10-01), None
patent: WO 00/05246 (2000-02-01), None
patent: WO 03/035621 (2003-05-01), None
patent: WO 03/035621 (2003-05-01), None
patent: WO 03/093498 (2003-11-01), None
Zhu et al. Activity-based fluorescent probes that target phosphatases. Tetrahedron letters, 2003, vol. 44, pp. 2669-2672.
Broadbridge et al. “p56lckSH2 Domain Binding Motifs From Bead Binding Screening of Peptide Libraries Containing Phosphotyrosine Surrogates”Letters in Peptide Science6: 335-341 (1999).
Burke et al. “Nonhydrolyzable Phosphotyrosyl Mimetics for the Preparation of Phosphatase-Resistant SH2 Domain Inhibitors”Biochemistry33: 6490-6494 (1994).
Burke, Jr. et al. “Preparation of Fluro- and Hydroxy-4-(phosphonomethyl)-D, L-phenylalanine Suitably Protected for Solid-Phase Synthesis of Peptides Containing Hydrolytically Stable Analogues of O-Phosphotyrosine”J Ory Chem58: 1336-1340 (1993).
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2005/012661 mailed on Jan. 12, 2006.
Kole et al. “Phosphonate Inhibitors of Protein-Tyrosine and Serine/teronine Phosphatases”Biochem Journal311: 1025-1031 (1995).
Kotoris et al. “Preparation of Chiral α-monofluoroalkylphosphonic Acids and Their Evaluation as Inhibitors of Protein Tyrosine Phosphatase 1B”J Chem Soc Perkin Trans 1pp. 1271-1281 (2000).
Kumar et al. “Activity-based Probes for Protein Tyrosine Phosphatases”PNAS101(21): 7943-7948 (2004).
Taylor et al. “Quiescent Affinity Inactivators of Protein Tyrosine Phosphatases”Bioorganic&Medicinal Chemistry4(9): 1515-1520 (1996).
Wang et al. “Naphthalenebis [α,α-Difluoromethylenephosphonates] as Potent Inhibitors of Protein Tyrosine Phosphatases”Bioorganic&Medicinal Chemistry Letters8: 345-350 (1998).
Andersen et al. “Structural and Evolutionary Relationships Among Protein Tyrosine Phosphatase Domains”Molecular and Cellular Biology21(21): 7117-7136 (2001).
Barford et al. “The Structure and Mechanism of Protein Phosphatases: Insight into Catalysis and Regulation”Annu Rev Biophys Biomol Struct27: 133-164 (1998).
Bleasdale et al. “Small Molecule Peptidomimetics Containing a Novel Phosphotyrosine Bioisostere Inhibit Protein Tyrosine Phosphatase 1B and Augment Insulin Action”Biochemistry40:5642-5654 (2001).
Burke et al. “Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2Pmp”Biochemical and Biophysical Research Communications204(1): 129-134 (1994).
Charifson et al. “Peptide Ligands of pp60c-src SH2 Domains: A Thermodynamic and Structural Study”Biochemistry36(21): 6283-6293 (1997).
Chen et al. “VHR and PTP1 Protein Phosphatases Exhibit Remarkably Different Active Site Specificities Toward Low Molecular Weight Nonpeptide Substrates”Biochemistry35: 9349-9354 (1996).
Chen et al. “Why is Phosphonodifluoromehtyl Phenylalanine a More portent Inhibitory Moiety than Phosphonomethyl Phenylalanine Toward Protein-Tyrosine Phosphatases?”Biochemical and Biophysical Research Communications216(3): 976-984 (1995).
Cohen et al. “The Development and Therapeutic Potential of Protein Kinases Inhibitors”Current Opinion in Chemical Biology3: 459-465 (1999).
Cravatt et al. “Chemical Strategies for the Global Analysis of Protein Function”Current Opinion in Chemical Biology4:663-668 (2000).
Desmarais et al. “[Difluro(phosphono)methyl]phenylalanine-containing Peptide Inhibitors of Protein Tyrosine Phosphatases”Biochemical Journal337(2): 219-556 (1999).
Gajda “Preparation of Diethyl 1-Bromoalkylphosphonates”Phosphorus, Sulfur, and Silicon53: 327-331 (1990).
Gavin et al. “Chiral Molecular Recognition in a Tripeptide Benzylviologen Cyclophane Host”J Org Chem63: 7663-7669 (1998).
Gordon et al. “Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions”Journal of Medicinal Chemistry37(10): 1385-1401 (1994).
Greenbaum “Epoxide Electrophiles as Activity-Dependent Cysteine Protease Profiling and Discovery Tools”Chemistry&Biology7: 569-581 (2000).
Griffiths et al. “Intramolecular Cyclisation of 2-vinyl- and 2-allylbenzoylphosphonates with Trimethyl Phosphite via Carbene Intermediates”ARKIVOC1(3): 304-311 (2000).
Huang et al. “Molecular Determinants of Substrate Recognition in Hematopoietic Protein-tyrosine Phosphatase” J Biol Chem 279: 52150-52159 (2004).
Huyer et al. “Affinity Selcetion from Peptide Libraries to Determine Substrate Specificity of Protein Tyrosine Phosphatases”Analytical Biochemistry258(1): 19-30 (1998).
Iversen et al. “Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B”The Journal of Biological Chemistry275(14): 10300-10307 (2000).
Jeffery et al. “Chemical Proteomics and its Application to Drug Discovery”Current Opinion in Biotechnology14: 87-95 (2003).
Kumar et al. “Activity-Based Probes for Protein Tyrosine Phosphatases”Proc Natl Acad Sci USA101(21): 7943-7948 (2004).
Lawrence et al. “Protein Kinase Inhibitors: The Tyrosine-Specific Protein Kinases”Pharmacology&Therapeutics77(2): 81-114 (1998).
Lee et al. “Tripeptide Inhibitors ofYersiniaProtein-tyrosine Phosphatase”Bioorganic and Medicinal Chemistry Letters13: 2577-2581 (2003).
Li et al. “Form, Function, and Regulation of Protein Tyr
Kumar Sanjai
Zhang Zhong-Yin
Albert Einstein College of Medicine of Yeshiva University
Amster Rothstein & Ebenstein LLP
Haq Shafiqul
LandOfFree
Activity-based probes for protein tyrosine phosphatases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activity-based probes for protein tyrosine phosphatases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activity-based probes for protein tyrosine phosphatases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4231922